fda warning letters glp-1 october 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading GLP‑1 Compliance: FDA Targets Telehealth

Patients may experience feeling sick, throwing up, diarrhea, and stomach pain

Many sulfonamide derivatives of metformin exerted cytotoxicity in human breast cancer cells (MCF-7 or MDA-MB-231, or both) induced particularly by methylated phenyl sulfonamides and was associated with their ability to arrest the cell cycle in the G0/G1 phase and subsequently to cause apoptosis (Torunoglu et al., 2023)

1, 2026, eligible Tricare beneficiaries in the Atlanta and Tampa metro areas can enroll in a new Tricare Prime option administered by CareSource Military and Veterans, a nonprofit managed-care organization

This personalized data helps clinicians optimize your medication selection and dosing, improving outcomes compared to standard treatment approaches

Steps to take right now to protect your claim Even if you have not decided whether to file a lawsuit, taking certain steps now protects your options for the future